This review provides substantial evidence supporting the exacerbation of prevalent lifestyle diseases, such as obesity, diabetes, chronic respiratory diseases, oral diseases, and cardiovascular diseases, by the NLRP3 inflammasome. Here, NLRP3 is linked to obesity disorder.